Blood cultures in community-acquired pneumonia: Are we ready to quit?

Chest

Volumn 123, Issue 4, 2003, Pages 977-978

  Luna, Carlos M ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTEREMIA; BLOOD CULTURE; COMMUNICABLE DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC APPROACH ROUTE; DISEASE SEVERITY; EDITORIAL; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMAN; NONHUMAN; PNEUMONIA; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; STREPTOCOCCUS PNEUMONIAE;

EID: 0037387577     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.4.977     Document Type: Editorial

References (17)

1. Bryan CS. Blood cultures for community-acquired pneumonia: no place to skimp! Chest 1999; 116:1153-1155
2. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults: Infectious Diseases Society of America. Clin Infect Dis 2000; 31:347-382
3. Mandell LA, Marrie TJ, Grossman RF, et al. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society; The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis 2000; 31:383-421
4. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia; diagnosis, assessment, of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-1754
5. British Thoracic Society guidelines for the management of community acquired pneumonia in adults. Thorax 2001; 56(Suppl 4):1-64
6. Marrie TJ. Community-acquired pneumonia. Clin Infect Dis 1994; 18:501-513
7. Barlett JG, Mundy LM. Community acquired pneumonia. N Engl J Med 1995; 333:1618-1624
8. Luna CM, Famiglietti A, Absi R, et al. Community-acquired pneumonia: etiology, epidemiology and outcome at a teaching hospital in Argentina. Chest 2000; 118:1344-1354
9. Theerthakarai R, El-Halees W, Ismail M, et al. Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia. Chest 2001; 119:181-184
10. Meehan T, Fine M, Krumholz H, et al. Quality of care, process and outcomes in elderly patients with pneumonia. JAMA 1997; 278:2080-2084
11. Torres A, Serra-Battles J, Ferrer A, et al. Severe community-acquired pneumonia: epidemiology and prognostic factors. Am Rev Respir Dis 1991; 144:312-318
12. Leroy O, Georges C, Beuscart B, et al. Severe community-acquired pneumonia in the intensive care unit: prospective validation of a prognostic score. Intensive Care Med 1996; 22:1307-1314
13. Waterer GW, Wunderink RG. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med 2001; 95:78-82
14. Waterer GW, Jennings SG, Wunderink RG. The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia. Chest 1999; 116:1842-1843
15. Moine P, Vercken JB, Chevret S, et al. Severe community-acquired pneumonia: etiology, epidemiology and prognosis factors; French study group for community-acquired pneumonia in the Intensive Care Unit. Chest 1994; 105:1487-1495
16. Moroney JF, Fiore AE, Harrison LH, et al. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis 2001; 33:797-805
17. Dedier J, Singer DE, Chang Y, et al. Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med 2001; 161:2099-2104